Detalhe da pesquisa
1.
Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non-Small Cell Lung Cancer Using a Clinicogenomic Database.
JAMA
; 321(14): 1391-1399, 2019 04 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30964529
2.
Somatic HLA Class I Loss Is a Widespread Mechanism of Immune Evasion Which Refines the Use of Tumor Mutational Burden as a Biomarker of Checkpoint Inhibitor Response.
Cancer Discov
; 11(2): 282-292, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33127846